First Time Loading...
E

Evotec SE
XETRA:EVT

Watchlist Manager
Evotec SE
XETRA:EVT
Watchlist
Price: 8.4 EUR 0.72% Market Closed
Updated: Jun 16, 2024
Have any thoughts about
Evotec SE?
Write Note

Evotec SE
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Evotec SE
Total Liabilities & Equity Peer Comparison

Comparables:
GXI
S
1SXP

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
E
Evotec SE
XETRA:EVT
Total Liabilities & Equity
€2.2B
CAGR 3-Years
12%
CAGR 5-Years
20%
CAGR 10-Years
26%
Gerresheimer AG
XETRA:GXI
Total Liabilities & Equity
€3.5B
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
8%
S
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Total Liabilities & Equity
€1.2B
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Evotec SE's Total Liabilities & Equity?
Total Liabilities & Equity
2.2B EUR

Based on the financial report for Mar 31, 2024, Evotec SE's Total Liabilities & Equity amounts to 2.2B EUR.

What is Evotec SE's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
26%

Over the last year, the Total Liabilities & Equity growth was -2%. The average annual Total Liabilities & Equity growth rates for Evotec SE have been 12% over the past three years , 20% over the past five years , and 26% over the past ten years .